chitosan has been researched along with Leukoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arefian, E; Atyabi, F; Dinarvand, R; Mahbod, M; Shahosseini, S; Soleimani, M; Vakhshiteh, F; Zahir-Jouzdani, F | 1 |
| Baratta, F; Battaglia, L; Bussano, R; Chirio, D; Gallarate, M; Peira, E; Trotta, M | 1 |
2 other study(ies) available for chitosan and Leukoma
| Article | Year |
|---|---|
Chitosan and thiolated chitosan: Novel therapeutic approach for preventing corneal haze after chemical injuries.
Topics: Animals; Biocompatible Materials; Cell Differentiation; Cell Proliferation; Chitosan; Corneal Injuries; Corneal Neovascularization; Corneal Opacity; Cysteine; Fibroblasts; Humans; Interleukin-6; Latent TGF-beta Binding Proteins; Male; Mice; Mice, Inbred BALB C; Myofibroblasts; Nanoparticles; Wound Healing | 2018 |
Development of O/W nanoemulsions for ophthalmic administration of timolol.
Topics: Administration, Ophthalmic; Adrenergic beta-Antagonists; Animals; Biological Availability; Chitosan; Corneal Opacity; Disease Models, Animal; Drug Delivery Systems; Drug Stability; Emulsions; In Vitro Techniques; Nanotechnology; Rabbits; Sodium Hydroxide; Succinates; Timolol | 2013 |